Search clinical trials for: Sodium-GLucose coTransporter-2 inhibitors
Total 9185 results
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
AstraZenecaBristol-Myers SquibbCompletedType 1 Diabetes MellitusUnited States, Germany, Belgium, Canada, Japan, Chile, United Kingdom, Poland, Netherlands, Argentina, Sweden, Russian Federation, Switzerland
-
Beth Israel Deaconess Medical CenterJanssen Scientific Affairs, LLCCompletedObesity | Overweight | Type 2 DiabetesUnited States
-
Merck Sharp & Dohme LLCPfizerCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedObesity | Diabetes Mellitus, Type 2United States, Belgium, Bulgaria, Colombia, Czech Republic, Finland, France, Germany, Guatemala, Mexico, Peru, Russian Federation, Spain, Ukraine
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2 | Renal InsufficiencyUnited States, Canada, France, Hong Kong, India, Malaysia, Netherlands, Philippines, Poland, Portugal, Russian Federation, Slovakia, South Africa, Spain, United Kingdom
-
Sequana Medical N.V.Active, not recruitingHeart Failure | Volume OverloadGeorgia
-
Amsterdam UMC, location VUmcRecruitingIdiopathic Pulmonary Arterial HypertensionNetherlands
-
Oregon State UniversitySamaritan Health ServicesRecruitingPreDiabetes | Prediabetic State | Overweight and ObesityUnited States
-
Washington University School of MedicineThe Foundation for Barnes-Jewish HospitalNot yet recruitingProstate Cancer | Cancer of ProstateUnited States
-
University of Texas Southwestern Medical CenterBoehringer IngelheimCompletedDiabetes Mellitus | Heart Failure, Diastolic | Heart Failure With Preserved Ejection FractionUnited States
-
University of RochesterAstraZenecaCompleted
-
Zhijun SunEnrolling by invitationHeart Failure | Heart Failure With Preserved Ejection Fraction | Heart Failure With Mid Range Ejection FractionChina
-
Mansoura UniversityActive, not recruitingLupus Nephritis | BMD | SGLT2 INHIBITORSEgypt
-
Tulane University School of MedicineAstraZenecaCompletedHypertension | Type 2 DiabetesUnited States
-
AstraZenecaParexel; PRA Health Sciences; Q2 Solutions; Covance Laboratories, IncCompletedType 2 DiabetesUnited States, Israel, Hungary, Russian Federation, Mexico, Romania, United Kingdom
-
University of PisaCompletedEnd Stage Renal DiseaseItaly
-
Johnson & Johnson Private LimitedCompleted
-
Novartis PharmaceuticalsCompletedObesity | OverweightAustria, United Kingdom, United States, Slovakia, Hungary, Czechia, Canada
-
Isfahan University of Medical SciencesCompletedDiabetes MellitusIran, Islamic Republic of
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
Astellas Pharma IncCompletedType 1 Diabetes MellitusJapan
-
AstraZenecaAntaros Medical; Bioventure Hub; 43183 Mölndal; SwedenCompletedType 2 Diabetes MellitusFinland
-
AstraZenecaAstra Zeneca, Bristol-Myers SquibbCompletedType 2 Diabetes MellitusUnited States
-
Boehringer IngelheimCompleted
-
The George InstituteUniversity Medical Center Groningen; Australian and New Zealand Intensive Care...RecruitingAcute Kidney InjuryAustralia
-
University of PatrasRecruiting
-
China National Center for Cardiovascular DiseasesRecruitingHypertrophic Cardiomyopathy | Heart Failure With Preserved Ejection FractionChina
-
4th Military Clinical Hospital with Polyclinic,...RecruitingHeart Failure | Breast CancerPoland
-
Eli Lilly and CompanyRecruitingType 2 DiabetesUnited States, Taiwan, China, Mexico, Germany, Poland
-
Central Hospital, Nancy, FranceNot yet recruiting
-
October 6 UniversityCairo University; National Heart Institute, EgyptRecruitingDiabetes Mellitus | Chronic Heart Failure | Acute Heart FailureEgypt
-
Frank RuschitzkaAstraZenecaRecruiting
-
University of Sao PauloCompletedDiabetes Mellitus, Type 2 | Coronary Heart Disease | Arrythmia, CardiacBrazil
-
Boehringer IngelheimEli Lilly and CompanyActive, not recruiting
-
Albert Einstein Healthcare NetworkSuspendedAcute Kidney Injury | Percutaneous Coronary InterventionUnited States
-
Vanderbilt University Medical CenterCompletedObesity | Pre-diabetesUnited States
-
AstraZenecaCompletedChronic Kidney DiseaseUnited States, Italy, Spain, Brazil, Malaysia, Australia, South Africa, Hungary, Georgia, Japan, Bulgaria, Poland, Ukraine, Denmark, Argentina, Slovakia, Canada, Croatia, Netherlands
-
Insel Gruppe AG, University Hospital BernCompleted
-
Novo Nordisk A/SCompletedHealthy VolunteersGermany
-
Stanford UniversityCompletedLiver Cirrhosis | Cirrhosis | Ascites | Ascites Hepatic | Sodium-Glucose Transporter 2 InhibitorsUnited States
-
Steno Diabetes Center CopenhagenUniversity of CopenhagenCompletedType 2 Diabetes | Maturity-Onset Diabetes of the Young, Type 3Denmark
-
University Hospital Inselspital, BerneCompletedDiabetes Mellitus, Type 1Switzerland
-
University of Campinas, BrazilCompletedEnd-stage Renal DiseaseBrazil
-
Washington University School of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedPancreatic Cancer | Pancreas Cancer | Cancer of the PancreasUnited States
-
Zhijun SunEnrolling by invitationHeart Failure | Heart Failure With Preserved Ejection FractionChina